Galaxy Digital Holdings Ltd. ( BRPHF) Q4 2025 Earnings Call February 3, 2026 8:30 AM EST ...

Good day, everyone, and welcome to Pfizer's Fourth Quarter 2025 Earnings Conference Call. Today's call is being recorded. At ...

The market for TIGIT inhibitors is expected to grow significantly in the coming years. This is due to the increasing number ...

The market for TIGIT inhibitors is expected to grow significantly in the coming years. This is due to the increasing number of patients who are being diagnosed with NSCLC, RCC, colorectal cancer ...

Dr. James McCaffrey presents a complete end-to-end demonstration of linear regression with pseudo-inverse training implemented using JavaScript. Compared to other training techniques, such as ...

What FM Nirmala Sitharaman announced on infrastructure, banking, health, education and tourism. Follow The Hindu for more ...

The deal underscores a broader shift in autoimmune drug development toward therapies that aim to reprogram disease-driving ...

The DUB inhibitors market is poised for steady growth, driven by rising interest in targeted protein degradation and novel oncology therapeutics. The ...

The DUB inhibitors market is poised for steady growth, driven by rising interest in targeted protein degradation and novel oncology therapeutics. The growing prevalence of cancer and neurodegenerative ...

After that, Pascal will provide a little more color on our fourth quarter performance, planned changes to our segment reporting next quarter, and key drivers of our financial guidance through 2028.

Thank you, Ashish, and good morning, everyone. This is a great example of the steps people in our business are willing to take to support their employees and manage events outside of their control.